Tuesday, 02 January 2024 12:17 GMT

Eye Health Ingredients Top Global Industry Trends In 2026


(MENAFN- EIN Presswire) EINPresswire/ -- The global eye health ingredients industry is projected to reach USD 360.3 million by 2035, expanding from USD 174.8 million in 2025 at a CAGR of 7.5%. Growth is fueled by increasing consumer awareness around preventive eye health, heavy screen exposure, and rising age-related vision issues. As consumers adopt nutraceuticals, fortified foods, and ocular supplements, demand for carotenoids, omega-based compounds, and botanical extracts continues to scale across retail and healthcare channels.

This decade is set to unlock nearly USD 185.5 million in new revenue potential, as companies shift towards premium formulations targeting digital eye strain, macular degeneration, and cataract prevention. The commercial landscape is anchored by rapid product innovation, clinical validations, and expanded accessibility through e-commerce and mass retail.

Explore trends before investing – request a sample report today!

Market Landscape Reinforced by Natural Ingredient Dominance

Natural sources will account for 64.8% of the market in 2025, with strong demand for plant-derived carotenoids and clean-label formulations. Consumers increasingly favor products made from marigold flowers, bilberry, and plant-based omega-3s, appreciating perceived safety, better absorption, and traceability. Regulatory approvals across advanced markets continue to support commercialization, accelerating the shift toward transparent, sustainable sourcing.

Lutein Stays at the Forefront of Eye Health Solutions

Lutein is expected to command 39.5% of ingredient revenue in 2025, driven by extensive clinical documentation linking it to retinal protection and blue light damage reduction. Increased consumption by aging populations and digital device users is setting the stage for expansive product portfolios spanning supplements, functional beverages, and fortified snacks. Advancements in purification and extraction technologies now enable high-stability, high-potency lutein formulations.

Soft Gel Formats Lead Due to Convenience and Bioavailability

Soft gels are projected to capture 41.7% of market revenue in 2025, supported by their superior delivery efficiency for omega-3s, lutein, and zeaxanthin. This format offers targeted dosing, stability, and user-friendly consumption-key factors in long-term ocular health supplementation. Manufacturers are investing in multi-ingredient soft gels combining omega-3s, carotenoids, and antioxidants in a single dose.

Strategic Growth Drivers

Growing demand is being propelled by:

.Rising preventive care awareness across high-risk demographics
.Screen-induced eye fatigue affecting global populations
.Nutraceutical-based eye care replacing reliance on medical procedures
.Increased incorporation into functional beverages, dairy, cereals, and premium supplements

However, ingredient pricing volatility, strict regulatory approvals, and sourcing limitations in carotenoid-rich botanicals continue to challenge scalability and operational pricing strategies.

Country-Level Performance Highlights

The global market's 7.5% CAGR is driven by strong adoption in Asia and sustained growth in Western markets:

.China: 10.1% CAGR, accelerated by digital eye strain prevalence and fortified food adoption
.India: 9.4% CAGR, supported by youth-focused preventive supplements and urban nutraceutical growth
.France: 7.9% CAGR, led by premium formulations and aging population needs
.U.K.: 7.1% CAGR, supported by strong retail penetration and EFSA-backed claims
.U.S.: 6.4% CAGR, reflecting a mature but high-value supplement ecosystem

Request customized market intelligence for eye health ingredients now!

Competitive Landscape

Global competition is defined by scientific validation and robust ingredient documentation. Companies differentiate through clinically backed brochures, formulation flexibility, and bioavailability claims.

Key Market Participants Include:

Alcon, Amway, MacuShield, Efamol, Swanson Bausch & Lomb, Solgar, BASF, FMC Corporation, Allied Biotech Corporation, DSM.

Why FMI:

About Future Market Insights (FMI)
Future Market Insights, Inc. (FMI) is an ESOMAR-certified, ISO 9001:2015 market research and consulting organization, trusted by Fortune 500 clients and global enterprises. With operations in the U.S., UK, India, and Dubai, FMI provides data-backed insights and strategic intelligence across 30+ industries and 1200 markets worldwide.

MENAFN23112025003118003196ID1110386038



EIN Presswire

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search